Table 5.

Overview of experimental flow for the drug study. Conditions and task orders are further outlined in Table 6

	Drug Study
Timepoint:	Enrolment	Session 1	Session 2
Enrolment:
Eligibility screen	X
Informed consent	X	X
Condition Allocation	X
Intervention:
Groups 1A & 1B Placebo		X
Groups 1A & 1B Lorazepam			X
Groups 2A & 2B Placebo			X
Groups 2A & 2B Lorazepam		X
MRI:
Groups 1A & 2A fMRI Tasks (visual-motor)		X
Groups 1A & 2A fMRI Tasks (motor-visual)			X
Groups 1B & 2B fMRI Tasks (visual-motor)			X
Groups 1B & 2B fMRI Tasks (motor-visual)		X
All Groups fMRI Resting State		X	X